ranitidine has been researched along with Bright Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Manire, CA; Rhinehart, HL | 1 |
Asano, Y; Ebihara, A; Ikeda, T; Kondo, K; Nakazawa, K; Ohashi, K; Tabei, K; Tagawa, H; Yamakado, M; Yuhara, M | 1 |
2 other study(ies) available for ranitidine and Bright Disease
Article | Year |
---|---|
Use of human recombinant erythropoietin for the treatment of nonregenerative anemia in a rough-toothed dolphin (Steno bredanensis).
Topics: Anemia; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Dolphins; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Flow Cytometry; Gentamicins; Glomerulonephritis; Hematocrit; Hematuria; Hemoglobins; Male; Proteinuria; Ranitidine; Recombinant Proteins; Reference Values; Sucralfate | 2000 |
Dosage regimen of ranitidine in patients with renal impairment.
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Creatinine; Female; Glomerulonephritis; Humans; Infusions, Intravenous; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Nephritis; Nephrotic Syndrome; Pyelitis; Ranitidine; Time Factors | 1989 |